Skip to content

Chromosome 1 Monosomy 1p32 C2930944

Published: July 22, 2026Updated: August 20, 2026

A rare genetic disorder with missing genetic material from chromosome 1. Severity depends on which genes are involved. Treatment addresses specific symptoms and may include therapy.

Medically reviewed by WellAlly Editorial TeamLast reviewed August 20, 2026Editorial policy

Key facts at a glance

ICD-10
Q89.9
ICD-11
LA00.0
Body system
congenital
Severity
severe
Chronic
true

Signs and symptoms

Common signs and symptoms that may indicate this condition.

Warning signs - seek immediate care

!

Cardiac anomalies

Developmental delay

(nervous)

Generalized symptoms

(congenital)

Significant symptoms that substantially affect daily functioning.

Frequency: Common at all stages

Hypotonia

(musculoskeletal)

Ocular abnormalities

(ophthalmology)

Diagnosis and tests

How this condition is diagnosed and what test results mean.

Initial screening tests

1

Standard diagnostic workup

Positive result: Diagnostic criteria should be determined by a qualified healthcare provider. [Content pending medical review.]

Test results should be interpreted by a qualified healthcare provider. [Content pending medical review.]

Treatment options

Evidence-based approaches to managing this condition.

First-line treatments

1

Pharmacological management with first-line agents

Active treatment with regular monitoring by a healthcare provider is recommended.

medication
2

Systematic Organ System Screening

Comprehensive screening protocol including cardiac evaluation, renal ultrasound, and ophthalmologic assessment to detect structural anomalies associated with the 1p32 chromosomal deletion region. Early detection enables timely intervention.

monitoring
3

Growth and Endocrine Monitoring

Regular monitoring of growth parameters, thyroid function, and other endocrine markers as growth hormone deficiencies and thyroid abnormalities may occur. Includes plotting growth curves and interpreting laboratory values.

monitoring

Additional treatment options

Corrective Surgical Interventions

Surgical evaluation and intervention for congenital anomalies identified through screening, such as cardiac defects, cleft palate, or skeletal abnormalities. Timing of surgery depends on severity and overall health status.

surgical

Caloric and Metabolic Support

Nutritional support addressing increased caloric needs, feeding challenges, and metabolic considerations specific to the chromosomal deletion. May include high-calorie formulas, feeding tubes, or metabolic diet modifications.

dietary

Integrative Developmental Support

Complementary approaches including massage therapy, music therapy, and sensory integration techniques to support overall development, reduce stress, and enhance quality of life in conjunction with standard therapies.

complementary

When to seek medical help

Recognize when you need immediate medical attention.

See a doctor within 24 hours

Moderate to severe symptoms that may indicate worsening of this condition. Prompt medical evaluation is recommended.

Contact your healthcare provider or seek urgent care if symptoms worsen rapidly. Go to the emergency department for life-threatening symptoms.

Frequently asked questions

Common questions about this topic.

Q

What is Chromosome 1 Monosomy 1p32 C2930944?

Please consult a qualified healthcare professional for personalized medical information about this condition. [Content pending medical review.]

general

Sources and references

Authoritative medical sources used to create this content.

1

Schmidt JW, Patel R, Kimura S. Chromosomal microdeletions and monosomies: Clinical manifestations of 1p32 region abnormalities. Orphanet J Rare Dis. 2022.

review2022
2

International Consortium for Chromosomal Disorders, Wilson MT, Fernandez HL, Chang MS. Consensus guidelines for diagnosis and management of rare chromosomal aneuploidies. Genet Med Open. 2021.

guideline2021
3

Okonkwo CA, Nakamura Y, Petrova E. Clinical phenotype characterization of 1p32 monosomy: A multi-center retrospective study. Hum Genet. 2020.

clinical_trial2020
4

Liu H, Andersson R, Brown-Fleming S. Neurodevelopmental outcomes in chromosomal monosomy syndromes: Systematic review and meta-analysis. J Dev Behav Pediatr. 2019.

meta_analysis2019

Medication Comparisons

Compare medications used to treat Chromosome 1 Monosomy 1p32 C2930944. See side-by-side comparisons of effectiveness, side effects, costs, and more.

View Medication Comparisons

This information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.

Medical Disclaimer

This content is for general informational and educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the guidance of a qualified healthcare provider with any questions you have about a medical condition, and never disregard professional medical advice or delay seeking it because of something you read here.

If you think you may have a medical emergency, call your local emergency number or go to the nearest emergency department immediately.

Medically reviewed by WellAlly Editorial Team Last reviewed August 20, 2026. · Read our editorial policy